Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesCooperative activation of human papillomavirus type 8 gene expression by the E2 protein and the cellular coactivator p300.Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell developmentDirect interaction between nucleosome assembly protein 1 and the papillomavirus E2 proteins involved in activation of transcriptionMEF2 transcription factors: developmental regulators and emerging cancer genesStructure of p300 bound to MEF2 on DNA reveals a mechanism of enhanceosome assemblyRepression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophyThe transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortinCardiac p300 is involved in myocyte growth with decompensated heart failureA novel complex regulates cardiac actin gene expression through interaction of Emb, a class VI POU domain protein, MEF2D, and the histone transacetylase p300Characterization of a cardiac-specific enhancer, which directs {alpha}-cardiac actin gene transcription in the mouse adult heartA ternary complex of transcription factors, Nishéd and NFATc4, and co-activator p300 bound to an intronic sequence, intronic regulatory element, is pivotal for the up-regulation of myosin light chain-2v gene in cardiac hypertrophy.WeederH: an algorithm for finding conserved regulatory motifs and regions in homologous sequencesp300 Functions as a coactivator of transcription factor GATA-4.Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition.FOG-2 competes with GATA-4 for transcriptional coactivator p300 and represses hypertrophic responses in cardiac myocytes.Evolution of the heart from bacteria to man.Epigenetic regulation of cardiac myocyte differentiation.Regulation of heart development and function through combinatorial interactions of transcription factors.The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.MicroRNA-20a constrains p300-driven myocardial angiogenic transcription by direct targeting of p300.Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300.Activation of GATA4 gene expression at the early stage of cardiac specification.Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy.Signaling and transcriptional networks in heart development and regeneration.Chromatin modifications remodel cardiac gene expression.Epigenetics of the failing heart.The control operated by the cell cycle machinery on MEF2 stability contributes to the downregulation of CDKN1A and entry into S phase.Role of the LF-SINE-Derived Distal ISL1 Enhancer in Patients with Classic Bladder Exstrophy.Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface.
P2860
Q21284678-F570C031-6573-43A2-817F-668D11379994Q24309427-D6CD9B17-B869-4DB0-A78D-75175EC7F72CQ24537650-8F08ABD0-3226-4939-A761-1B4369665233Q24607374-CE3C08AC-017C-4207-9628-0E7D8EA1D20BQ26778515-9B6FB629-2D1A-40A2-9BB1-63F3DD4FD09CQ27666773-077A5FF2-398E-4425-840B-32CDD5A98F03Q28571438-8DAB4533-8EF8-47E3-B242-FFEDDA3D8A16Q28572612-3518E9A2-4FAF-4545-B766-FA594C944EFDQ28576829-60590860-475B-4DAD-91A8-BC0335D936B6Q28588306-4FD2FF0C-7E85-4DE7-B993-84ABE12AF942Q28592640-CD36ACC1-D60F-4CE5-B492-B08EA3E65CB5Q33205146-60D3BB42-9E2D-4B82-8258-7B70957C0274Q33272665-01A75275-9BC7-40C7-B09D-C68CD62D5632Q33289336-64700E4A-B30E-44CF-8DC3-76D929F0755EQ34035076-F14450AF-378D-4A0A-88B1-24A94DFB1AC6Q34329447-00663840-35F8-48FE-8856-944EF3C65F64Q34442031-DF8745CB-1D2B-4DF3-9036-6EE6FDB25C6CQ34449181-CF34837B-6E5D-429E-A8F4-2D4008BD2F81Q34510777-8ECA140D-4D69-4F06-906C-A685AD21B2FFQ34778695-CA804B7B-EA9D-4AF0-9418-62C10BCB9D2AQ35043713-76A863A9-CE34-45F5-8C40-0ABBD170625FQ37303806-A00419A5-A5A5-44A5-9606-9D716C656C19Q37696081-7884C4EC-4E96-4015-B02F-FD3AF5AD9789Q38023555-F56D6B62-07F6-47B3-AAE7-60CDEB985768Q38086222-6A615FC5-728E-4BC7-9915-F2FD2DA5C77CQ38210525-8C7DD96A-3A04-4ECF-89E9-9DDB5166E1A7Q38408408-C404FAE5-896F-44E3-9D0E-D5C7713BF328Q38904419-82E60449-9FAC-408A-B812-B07FA34BD391Q40088424-E5E22D94-C413-4932-BF2F-4D2B0AD9B8DDQ42367637-7FD59468-D22F-4C89-9510-CEF0CFAEFFB8
P2860
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@ast
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@en
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@nl
type
label
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@ast
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@en
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@nl
prefLabel
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@ast
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@en
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@nl
P2093
P356
P1476
Control of cardiac-specific transcription by p300 through myocyte enhancer factor-2D
@en
P2093
H Prentice
K A Webster
N H Bishopric
T I Slepak
P304
P356
10.1074/JBC.M004625200
P407
P577
2001-03-09T00:00:00Z